Michelle Haber Selected Research

Retinoic Acid Receptors (Retinoic Acid Receptor)

5/2009	The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation.
3/2003	Combined RAR alpha- and RXR-specific ligands overcome N-myc-associated retinoid resistance in neuroblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle Haber Research Topics

Disease

99	Neoplasms (Cancer) 02/2024 - 09/2003
73	Neuroblastoma 01/2024 - 03/2003
17	Carcinogenesis 10/2023 - 07/2003
15	Leukemia 04/2024 - 06/2002
14	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 02/2003
10	Breast Neoplasms (Breast Cancer) 12/2022 - 07/2003
6	Residual Neoplasm 08/2015 - 02/2003
4	Brain Neoplasms (Brain Tumor) 12/2021 - 06/2015
4	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 05/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 11/2014
3	Glioma (Gliomas) 01/2023 - 01/2018
3	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 09/2021
3	Ovarian Epithelial Carcinoma 04/2022 - 07/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2020
3	Lung Neoplasms (Lung Cancer) 10/2019 - 05/2009
2	Rheumatoid Arthritis 02/2024 - 01/2021
2	Hyperplasia 10/2023 - 08/2004
2	Diffuse Intrinsic Pontine Glioma 12/2021 - 01/2021
2	Hypoxia (Hypoxemia) 01/2020 - 10/2007
2	Neoplasm Metastasis (Metastasis) 08/2016 - 04/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2013 - 02/2012
1	Alcoholism (Alcohol Abuse) 02/2024

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2003
12	multidrug resistance-associated protein 1IBA 01/2022 - 01/2004
11	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2021 - 01/2010
10	Histone Deacetylase InhibitorsIBA 01/2023 - 06/2006
9	EnzymesIBA 04/2021 - 09/2007
9	Oncogene Proteins (Oncogene Protein)IBA 04/2021 - 02/2010
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2014
8	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2016
8	Small Interfering RNA (siRNA)IBA 04/2022 - 10/2007
8	Adenosine Triphosphate (ATP)IBA 10/2020 - 09/2008
7	Vincristine (Oncovin)FDA LinkGeneric 10/2023 - 06/2002
7	PolyaminesIBA 12/2021 - 12/2008
7	RetinoidsIBA 08/2015 - 03/2003
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2012
5	Drug CombinationsIBA 01/2023 - 01/2020
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 11/2007
5	CBLC137IBA 01/2022 - 11/2015
5	ChromatinIBA 01/2022 - 05/2009
5	Eflornithine (Ornidyl)FDA Link 01/2019 - 12/2008
4	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2016
4	Messenger RNA (mRNA)IBA 10/2020 - 01/2016
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2019 - 05/2011
4	Indicators and Reagents (Reagents)IBA 01/2018 - 02/2003
4	Folic Acid (Vitamin M)FDA LinkGeneric 06/2015 - 06/2010
3	Histones (Histone)IBA 01/2023 - 05/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 07/2002
3	PanobinostatIBA 01/2022 - 01/2019
3	N-Myc Proto-Oncogene ProteinIBA 11/2019 - 06/2011
3	Long Noncoding RNAIBA 11/2019 - 04/2014
3	CationsIBA 01/2019 - 01/2012
2	Auranofin (Ridaura)FDA Link 02/2024 - 01/2021
2	Topotecan (Hycamtin)FDA LinkGeneric 02/2024 - 01/2024
2	Etoposide (VP 16)FDA LinkGeneric 02/2024 - 08/2009
2	Celecoxib (Celebrex)FDA Link 01/2024 - 09/2016
2	Vorinostat FDA Link 01/2023 - 08/2015
2	NucleosidesIBA 12/2022 - 04/2005
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2022 - 04/2017
2	CholesterolIBA 04/2022 - 07/2014
2	taxaneIBA 12/2021 - 02/2016
2	dipinacoline glutamateIBA 12/2021 - 01/2021
2	Complement System Proteins (Complement)IBA 12/2021 - 07/2015
2	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2020
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021 - 12/2020
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2021 - 06/2007
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 04/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 12/2020 - 01/2019
2	CopperIBA 10/2020 - 01/2016
2	Copper Transporter 1IBA 10/2020 - 01/2016
2	OT-82IBA 01/2020 - 01/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 09/2008
2	NAD (NADH)IBA 01/2020 - 01/2020
2	Carrier Proteins (Binding Protein)IBA 11/2019 - 11/2009
2	Caspase 2IBA 01/2019 - 05/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 04/2005
2	Tripartite Motif ProteinsIBA 05/2016 - 02/2012
2	Conditioned Culture MediaIBA 02/2016 - 11/2009
2	Methotrexate (Mexate)FDA LinkGeneric 06/2015 - 07/2002
2	LipidsIBA 01/2015 - 07/2014
2	reversanIBA 08/2011 - 08/2009
2	Protein Isoforms (Isoforms)IBA 02/2010 - 10/2009
2	Protein Glutamine gamma Glutamyltransferase 2IBA 02/2010 - 11/2007
2	Antisense OligonucleotidesIBA 07/2009 - 09/2003
2	retinoic acid receptor betaIBA 05/2009 - 06/2006
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 05/2009 - 03/2003
2	DNA (Deoxyribonucleic Acid)IBA 09/2007 - 07/2003
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2006 - 03/2003
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2024
1	Tyrosine (L-Tyrosine)FDA Link 02/2024
1	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2024
1	Disulfiram (Antabuse)FDA Link 02/2024
1	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2024
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2024

Therapy/Procedure

48	Therapeutics 04/2024 - 02/2003
26	Drug Therapy (Chemotherapy) 02/2024 - 02/2003
7	Immunotherapy 01/2023 - 07/2015
6	Precision Medicine 11/2023 - 01/2018
4	Radiotherapy 11/2021 - 07/2009
2	Combined Modality Therapy 01/2022 - 01/2021